INTERVENTIONS FOR VALVULAR DISEASE AND HEART FAILURE
A meta-analysis of the impact of pre-existing and new-onset atrial fibrillation on clinical outcomes in patients undergoing transcatheter aortic valve implantation
EuroIntervention 2016;12:e1047-e1056 published online ahead of print November 2015.
Anna Sannino1, MD; Giuseppe Gargiulo1, MD; Gabriele Giacomo Schiattarella1, MD; Cinzia Perrino1,2, MD, PhD; Eugenio Stabile1,2, MD; Maria-Angela Losi1,2, MD; Maurizio Galderisi1,2, MD; Raffaele Izzo1,2, MD; Giovanni de Simone2, MD; Bruno Trimarco1,2, MD; Giovanni Esposito1,2*, MD, PhD
1. Division of Cardiology, Department of Advanced Biomedical Sciences, Federico II University, Naples, Italy; 2. Hypertension Research Center, Federico II University, Naples, Italy
Aims: Little is known about the prognostic role of pre-existing atrial fibrillation (AF) and new-onset AF (NOAF) in transcatheter aortic valve implantation (TAVI). Therefore, the aim of t